Re: 'Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research' by Strawn JR and Croarkin PE (J Child Adolesc Psychopharmacol 2018;28:(5)363)
| Autor: | Phil Chappell, Deborah Chiles, Dalia B. Wajsbrot, Sara Ramaker, Karen L. Weihs |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Adolescent Psychopharmacology MEDLINE Placebo Child and adolescent Desvenlafaxine Succinate Fluoxetine Humans Medicine Pharmacology (medical) Child Psychiatry Depressive Disorder Major business.industry Original Articles medicine.disease Antidepressive Agents Desvenlafaxine Psychiatry and Mental health Pediatrics Perinatology and Child Health Major depressive disorder business medicine.drug |
| Zdroj: | Journal of Child and Adolescent Psychopharmacology. 29:245-246 |
| ISSN: | 1557-8992 1044-5463 |
| Popis: | Objective: The purpose of this study was to assess the effect of guanfacine extended release (GXR) adjunctive to a psychostimulant on oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|